HEGGIE THERESA bought BCRX

March 20, 2026 · Form 4 insider transaction

HEGGIE THERESA bought 49,933 shares of BioCryst Pharmaceuticals, Inc. at $6.30 per share, a transaction worth $314.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.